4.8 Letter

Resminostat: Opening the Door to Epigenetic Treatments for Liver Cancer

Journal

HEPATOLOGY
Volume 63, Issue 2, Pages 668-669

Publisher

WILEY
DOI: 10.1002/hep.27853

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available